A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer

JAMA: The Journal of the American Medical Association

Volumn 267, Issue 7, 1992, Pages 941-944

  London, Stephanie J ^a   Connolly, James L ^b   Schnitt, Stuart J ^b   Colditz, Graham A ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DISEASE CLASSIFICATION; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; HYPERPLASIA; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

BREAST; BREAST DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FIBROCYSTIC DISEASE OF BREAST; HUMAN; HYPERPLASIA; MENOPAUSE; MIDDLE AGE; PROSPECTIVE STUDIES; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026530997     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1992.03480070057030     Document Type: Article

References (14)

1. Foote FW, Stewart FW. Comparative studies of cancerous versus noncancerous breasts. Ann Surg. 1945;121:197-222.
2. Cancer Committee of the College of American Pathologists. Is ‘fibrocystic disease’ of the breast precancerous? Arch Pathol Lab Med. 1986;110:171-173.
3. Black MM, Barclay THC, Cutler SJ, Hankey BK, Asire AJ. Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer. 1972;29:338-343.
4. Kodlin D, Winger EE, Morgenstern NL, Chen U. Chronic mastopathy and breast cancer: a followup study. Cancer. 1977;39:2603-2607.
5. Donnelly PK. Baker KW, Carney JA, O’Fallon WM. Benign breast lesions and subsequent breast carcinoma in Rochester, Minnesota. Mayo Clin Proc. 1975;50:650-656.
6. Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B. Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst. 1980;65:13-20.
7. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146-151.
8. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16692 women with benign breast disease. Am J Epidemiol. 1988;128:467-477.
9. Dupont WD, Page DL. Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol. 1989;20:723-725.
10. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer. 1985;55:2698-2708.
11. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. Dietary fat and the risk of breast cancer. N Engl J Med. 1987;316:22-28.
12. Colditz GA. The Nurses’ Health Study: findings during 10 years of follow-up on a cohort of US women. Curr Probi Obstet Gynecol Fertil. 1990;13:129-174.
13. Breslow NE, Day NE. Statistical Methods in Cancer Research, I: The Analysis of Case Control Studies. Lyon, France: International Agency for Research on Cancer; 1980. International Agency for Research on Cancer scientific publication 32.
14. Key TJA, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Clin Oncol. 1988;24:29-43.